Evopoint Biosciences Co LtdSSE: 688837

(688837)"EVOPOINT BIOSCIENCES CO., LTD."Announcement on Obtaining Drug Registration Approval

· Issued by Evopoint Biosciences Co Ltd via Shanghai Stock Exchange

Filed with SSE · Stock code 688837 · · 4 pages · Chinese

Summary by 6ix AI

The drug is indicated for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. This approval enhances the company's competitive edge and sustainable development capabilities, although market conditions may affect sales.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Evopoint Biosciences Co Ltd on 6ix

Earlier from Evopoint Biosciences

All Evopoint Biosciences news releases